Series C · BiotechRatio Therapeutics: Series CDeveloping best-in-class radiopharmaceuticals for cancer treatmentPublished Oct 4, 2026By RoundOS Funding deskFunding historyJul 31, 2026Series C · This round$70MSourcesprnewswire.com↗
Isomorphic LabsBuilds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas$5BSeries C · Nov 17, 2026
Science CorporationDevelops brain-computer interface retinal implants to restore vision in patients with retinal diseases$400MSeries D · Nov 17, 2026
ZyaZya develops enzyme ingredients for food manufacturers, designed to transform nutrients after consumption.£11.5MSeries A · Nov 16, 2026
INFevoDevelops virtual-cell AI models and automated experimental workflows for biological research.>CN¥100MPre-A · Nov 16, 2026